000 | 01081 a2200289 4500 | ||
---|---|---|---|
005 | 20250513222853.0 | ||
264 | 0 | _c20001031 | |
008 | 200010s 0 0 eng d | ||
022 | _a0307-6938 | ||
024 | 7 |
_a10.1046/j.1365-2230.2000.00694.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchneeberger, A | |
245 | 0 | 0 |
_aManagement of malignant melanoma: new developments in immune and gene therapy. _h[electronic resource] |
260 |
_bClinical and experimental dermatology _cSep 2000 |
||
300 |
_a509-19 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntigens, Neoplasm _xtherapeutic use |
650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanoma _ximmunology |
700 | 1 | _aGoos, M | |
700 | 1 | _aStingl, G | |
700 | 1 | _aWagner, S N | |
773 | 0 |
_tClinical and experimental dermatology _gvol. 25 _gno. 6 _gp. 509-19 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2230.2000.00694.x _zAvailable from publisher's website |
999 |
_c10989169 _d10989169 |